PALO ALTO, Calif., Sept. 12, 2018 /PRNewswire/ -- Varian (NYSE: VAR)
today announced that Jeffrey R.
Balser, MD, PhD, president and chief executive officer at
Vanderbilt University Medical Center
and dean of Vanderbilt University
School of Medicine, has been appointed to the Varian Board of
Directors, effective October 1,
2018.
"We are very pleased that Jeff
Balser has joined the Varian board," said R. Andrew Eckert, chairman of Varian's Board of
Directors. "Jeff brings to Varian a diverse and proven skill set as
a physician, scientist and businessman. We look forward to his
contributions in assisting Varian's transformation from the leader
in radiation therapy to the leader in cancer care solutions."
"Varian has a well-earned reputation as a strong mission-driven
company developing and delivering innovative cancer care
solutions," said Dr. Balser. "I look forward to working with my
fellow Board members and the Varian team to continue the company's
growth efforts in creating a world without the fear of cancer."
Dr. Balser, 56, has served as the president and CEO of
Vanderbilt University Medical Center
since 2016 and the dean of Vanderbilt
University School of Medicine since 2008. During this time,
he has led the Medical Center through a period of increased service
volume with major inpatient expansions of the children's hospital
and the adult critical care areas. Dr. Balser earned his medical
and PhD degrees from Vanderbilt
University and completed his residency and fellowship
training at The Johns Hopkins Hospital. Additionally, he earned a
Bachelor of Science degree in Engineering from Tulane University.
About Varian
Varian is a leader in developing and
delivering cancer care solutions and is focused on creating a world
without fear of cancer. Headquartered in Palo Alto, California, Varian employs
approximately 7,000 people around the world. For more
information, visit http://www.varian.com and follow @VarianMedSys
on Twitter.
Press Contact
Mark
Plungy
Director, Public Relations
+1 (650) 424-5630
mark.plungy@varian.com
Investor Relations Contact
J. Michael Bruff
Senior Vice President, Investor Relations
+1 (650) 424-5163
investors@varian.com
View original
content:http://www.prnewswire.com/news-releases/dr-jeff-balser-named-to-varian-board-of-directors-300710939.html
SOURCE Varian